How Do You Spell ORNITHINE TRANSCARBAMYLASE DEFICIENCY DISEASE?

Pronunciation: [ˈɔːnɪθˌa͡ɪn tɹanskˈɑːbɐmˌɪle͡ɪs dɪfˈɪʃənsi dɪzˈiːz] (IPA)

Ornithine Transcarbamylase Deficiency Disease (OTCDD) is a rare genetic disorder that affects the body’s ability to process protein. The spelling of this word can be explained using the International Phonetic Alphabet (IPA) phonetic transcription, which breaks down each sound in the word. The first word, "ornithine," is pronounced as "ɔːˈnɪθiːn," while "transcarbamylase" is pronounced as "trænskɑːˈbæmɪleɪs." The final word, "deficiency," is pronounced as "dɪˈfɪʃənsi." The complex spelling of OTCDD reflects the complexity of this rare disease and the effort required to diagnose and treat it.

ORNITHINE TRANSCARBAMYLASE DEFICIENCY DISEASE Meaning and Definition

1. Ornithine Transcarbamylase Deficiency Disease, also known as OTC deficiency, is a rare genetic disorder that affects the body's ability to break down and eliminate waste products from protein metabolism. This condition is caused by a mutation in the OTC gene, which is responsible for producing the enzyme ornithine transcarbamylase.

   Ornithine transcarbamylase is necessary for the breakdown of ammonia, a toxic byproduct of protein metabolism, into a less harmful substance called urea. Urea is then excreted from the body through urine. However, in individuals with OTC deficiency, the lack or dysfunction of this enzyme leads to the buildup of ammonia in the bloodstream.

   As ammonia accumulates in the body, it can cause a wide range of symptoms, including lethargy, poor appetite, vomiting, seizures, behavior changes, and even coma. These symptoms typically occur during infancy or early childhood when protein-rich foods are introduced into the diet. In more severe cases, OTC deficiency may also lead to liver damage, cognitive impairment, and developmental delays.

   This condition is inherited in an X-linked recessive pattern, meaning it primarily affects males. Females who carry one copy of the OTC gene mutation are usually unaffected or experience milder symptoms. Treatment for OTC deficiency often involves a low-protein diet, medications to reduce ammonia levels, and sometimes liver transplantation in more severe cases.

   Overall, Ornithine Transcarbamylase Deficiency Disease is a genetic disorder that impairs the body's ability to process ammonia, leading to a wide range of symptoms that can vary in severity.

Common Misspellings for ORNITHINE TRANSCARBAMYLASE DEFICIENCY DISEASE

• irnithine transcarbamylase deficiency disease
• krnithine transcarbamylase deficiency disease
• lrnithine transcarbamylase deficiency disease
• prnithine transcarbamylase deficiency disease
• 0rnithine transcarbamylase deficiency disease
• 9rnithine transcarbamylase deficiency disease
• oenithine transcarbamylase deficiency disease
• odnithine transcarbamylase deficiency disease
• ofnithine transcarbamylase deficiency disease
• otnithine transcarbamylase deficiency disease
• o5nithine transcarbamylase deficiency disease
• o4nithine transcarbamylase deficiency disease
• orbithine transcarbamylase deficiency disease
• ormithine transcarbamylase deficiency disease
• orjithine transcarbamylase deficiency disease
• orhithine transcarbamylase deficiency disease
• ornuthine transcarbamylase deficiency disease
• ornjthine transcarbamylase deficiency disease
• ornkthine transcarbamylase deficiency disease
• ornothine transcarbamylase deficiency disease